Kristin Horwood ACNP-BC, AOCNP, MSN VEXAS Syndrome Overview VEXAS syndrome is a unique adult-onset disease with several varying clinical signs and symptoms. It is important for hematology/oncology advanced practice providers…
Beth Sandy, MSN, CRNP, FAPOThe most common type of squamous cell carcinoma of the head and neck (SCCHN) is oropharyngeal cancer, which arises from the back one-third of the throat,…
Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP, and Amy Barker, MSN, APRN, FNP-CWe have witnessed dismal overall outcomes in individuals with relapsed and/or refractory (R/R) multiple myeloma (MM) for many years. However,…
Manali Bhave, MD Triple-negative breast cancer (TNBC) accounts for 15% to 20% of all breast cancer cases1 and is characterized by aggressive disease associated with early recurrence and high mortality.…
Sijimol Mathew, DNP, APRN, ACNP-BC Insulinomas originate from the uncontrolled growth of pancreatic beta cells. Chronic and recurrent hypoglycemia lowers the patient’s threshold to hypoglycemic insults; additionally, early morning hypoglycemia…
Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP The bispecific antibodies have shown an impressive response rate with tolerable safety profile in patients with relapsed and refractory multiple myeloma (R/R MM). The Food…
Aileen Anglin, APRN, ACNP-BC, AOCNP Small-cell lung cancer (SCLC) accounts for about 15% of all lung cancers in the United States. It is a type of high-grade neuroendocrine carcinoma that…
Stephen Michael Clark, PharmD BCOP There have been some exciting advancements in immunotherapy for cancer in the past year, particularly hematologic malignancies. One such advancement is a group of therapies…
Jina Yun, PharmD Breast cancer is the most prevalent cancer in women in the United States, affecting 1 out of 8 women.1 It is the second leading cause of cancer-related…
Kathryn Green, MSN, ACNP-BC Hepatocellular cancer (HCC) is a common cancer globally, and there are more than 40,000 new cases yearly with an estimated 29,380 deaths per year in the…